Antibody-associated rejection in liver transplantation: Keep on knocking, and the door will be opened to you

American Journal of Transplantation

Volumn 11, Issue 9, 2011, Pages 1767-1768

  Briggs, D ^a   Adams, D H ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DACLIZUMAB; DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; OKT 3; UNCLASSIFIED DRUG;

ACUTE GRAFT REJECTION; ANTIBODY ASSOCIATED GRAFT REJECTION; ANTIBODY SPECIFICITY; B LYMPHOCYTE; CELL ACTIVATION; CHRONIC GRAFT REJECTION; EDITORIAL; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

AUTOANTIBODIES; B-LYMPHOCYTES; GRAFT REJECTION; HLA ANTIGENS; HUMANS; LIVER TRANSPLANTATION; RISK FACTORS; T-LYMPHOCYTES;

EID: 80052260696     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03595.x     Document Type: Editorial

References (7)

1. Knechtle SJ,. Seek and you will find: Antibody and the liver. Am J Transplant 2011; 11: 424-425.
2. O'Leary J, Kaneku H, Jennings L, et al,. High meanfluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection post-liver transplanation. Am J Transplant
3. Musat AI, Agni RM, Wai PY, et al,. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011; 11: 500-510.
4. Donaldson PT, Alexander GJ, O'Grady J, et al,. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation. Lancet 1987; 1: 945-951.
5. Higgins R, Hathaway M, Lowe D, et al,. Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: Resolution of rejection in the presence of circulating donor-specific antibody. Transplantation 2007; 84: 876-884. (Pubitemid 351338949)
6. Stegall MD, Gloor JM,. Deciphering antibody-mediated rejection: New insights into mechanisms and treatment. Curr Opin Organ Transplant 2010; 15: 8-10.
7. Kelishadi SS, Azimzadeh AM, Zhang T, et al,. Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys. J Clin Invest 2010; 120: 1275-1284.